Trial intelligence / Profile preview

Comparison of Antiproteinuric Effect Between High-dose and Low-dose Manidipine in Proteinuric CKD Patients

TCTR20260411008Phase 4Completed

Sponsor
Navamindradhiraj University
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of manidipine in chronic kidney disease (CKD), proteinuria, sponsored by Navamindradhiraj University. Started Sep 2017; status: completed.

02

Drugs

manidipine
03

Conditions

chronic kidney disease (CKD)proteinuria

Beyond the preview

Go deeper on TCTR20260411008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260411008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call